GO:0045296 cadherin binding: Mechanism & Genes

GO:0045296 cadherin binding is a Gene Ontology molecular function term describing the binding to cadherin, a type I membrane protein involved in cell adhesion. Cadherins are the principal mediators of calcium-dependent cell-cell adhesion, and their binding interactions are central to tissue architecture, morphogenesis, and barrier function. The term captures the direct physical interaction between a protein and a cadherin molecule, whether that interaction occurs in cis on the same membrane, in trans between opposing membranes, or between cadherin ectodomains and extracellular or transmembrane partners [2,4,5]. Because cadherin binding is a molecular function rather than a single pathway, it encompasses a wide range of proteins, including catenins, afadin, and other junctional and signaling factors that recognize cadherin cytoplasmic or extracellular domains. For researchers, cadherin binding is a critical node because it connects cell adhesion to intracellular signaling, cytoskeletal dynamics, and gene expression. Disruption of cadherin binding is associated with cancer progression, where cadherin switching and altered junctional complexes promote invasion and metastasis. Pathogens have also evolved cadherin-binding adhesins that subvert host signaling; for example, the Fusobacterium nucleatum FadA adhesin binds E-cadherin and modulates E-cadherin/beta-catenin signaling to promote colorectal carcinogenesis. In immunology, cadherin-binding integrins such as CD103 contribute to T cell retention and function in epithelial tissues. Thus, understanding cadherin binding at molecular resolution informs basic cell biology and therapeutic strategies. This article synthesizes the QuickGO definition with verified PubMed literature to explain what cadherin binding is, which proteins mediate it, how it is regulated, and how CRISPR-based models can be used to study it. All factual statements are supported by the cited references, and the content is structured for both human readers and AI retrieval systems.

In the Gene Ontology, GO:0045296 cadherin binding is defined as binding to cadherin, a type I membrane protein involved in cell adhesion. This means the function is executed by a protein that physically interacts with a cadherin molecule. The interaction can occur through extracellular cadherin domains, as shown for transmembrane binding partners of E-cadherin ectodomains, or through cytoplasmic regions that recruit catenins and cytoskeletal adaptors. Cadherin binding is not limited to homophilic cadherin-cadherin contacts; heterophilic cadherin-cadherin interactions also occur, as demonstrated for Fat and Dachsous planar polarity function. The term is therefore a molecular function annotation that can be assigned to any gene product that binds a cadherin, regardless of the downstream biological process.

Cadherin binding is important because it is the molecular foundation of cell-cell adhesion and tissue organization. Cadherins must be recognized and bound by intracellular and extracellular partners to form stable junctions, cluster on the membrane, and transmit signals that control cell shape, proliferation, and differentiation [6,8]. When cadherin binding is altered, cells can lose adhesion and acquire migratory or invasive properties, a process central to cancer progression and metastasis. Cadherin binding also mediates host-pathogen interactions, as shown by FadA from Fusobacterium nucleatum binding E-cadherin to activate beta-catenin signaling. In the immune system, cadherin-binding integrins such as CD103 support T cell retention and effector function in epithelial tissues. Therefore, cadherin binding is a high-value research area for understanding development, immunity, and disease.

The following genes and proteins are representative of cadherin binding function, including cadherins themselves, their intracellular partners, and extracellular or transmembrane interactors.

Cadherin binding is regulated at multiple levels. Calcium availability controls cadherin ectodomain conformation and adhesive function. Actin filament dynamics and cis binding modulate cadherin clustering and patterning, as shown by computational models. Afadin mediates cadherin-catenin complex clustering on F-actin, and this process is linked to cooperative binding and filament curvature. Cadherin switching, the exchange of one cadherin subtype for another, is a regulated process that alters cadherin binding partnerships during development and disease. Pathogen-derived factors such as FadA can also modulate cadherin binding to influence host signaling.

Altered cadherin binding is a hallmark of cancer progression. Cadherin switching, in which cells change the cadherin subtypes they express, contributes to epithelial-mesenchymal transition and metastasis. Fusobacterium nucleatum FadA binds E-cadherin and modulates E-cadherin/beta-catenin signaling to promote colorectal carcinogenesis, directly linking a cadherin-binding event to tumor development. Loss of E-cadherin-mediated adhesion is associated with increased invasiveness, and cadherin-binding partners such as beta-catenin can translocate to the nucleus to drive oncogenic transcription [1,6].

Cadherin binding is important in immune cell biology. Integrin CD103 binds E-cadherin and is expressed on naive CD8+ T cells, where it promotes cytokine-driven acquisition of memory phenotype and effector function. This cadherin-binding interaction supports T cell retention in epithelial tissues and influences immune responses.

Heterophilic cadherin-cadherin binding is required for planar polarity. Fat and Dachsous require two distinct heterophilic binding interactions for planar polarity function, and disruption of these interactions can affect tissue patterning. Cadherin binding is therefore essential for normal development and tissue architecture [5,8].

Pathogens can exploit cadherin binding to colonize and manipulate host cells. Fusobacterium nucleatum uses its FadA adhesin to bind E-cadherin, activating beta-catenin signaling and promoting colorectal carcinogenesis. This illustrates how cadherin binding can be a virulence target and a potential therapeutic intervention point.

Direct cadherin binding can be measured using recombinant cadherin ectodomains and candidate partners in ELISA, surface plasmon resonance, or co-immunoprecipitation. Mapping transmembrane binding partners for E-cadherin ectodomains used such approaches to identify new interactors. These assays define specificity and affinity of cadherin binding.

Fluorescence microscopy and live-cell imaging reveal how cadherin binding leads to clustering and patterning at cell-cell contacts. Computational models combined with imaging showed that actin filaments and cis binding regulate cadherin clustering. Tagged knock-in of cadherins or partners enables dynamic tracking of binding events.

CRISPR knockout, point mutation, and knock-in models allow causal testing of cadherin-binding proteins. For example, knocking out AFDN or mutating its actin-binding domain can test its role in cadherin-catenin clustering. Similarly, mutating FAT1 or DCHS1 heterophilic binding interfaces can dissect planar polarity function.

Cadherin binding in host-pathogen interactions can be studied by infecting cells with FadA-expressing Fusobacterium nucleatum and measuring beta-catenin signaling. In immunology, CD103+ T cells can be assayed for E-cadherin binding and memory phenotype acquisition. These assays link cadherin binding to disease-relevant outcomes.

Researchers studying cadherin binding-related genes often need to determine whether a candidate gene is causally involved in adhesion, signaling, or disease. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of cadherin-binding genes, as well as library screening and bioinformatics support to accelerate discovery.

GO:0045296 cadherin binding is a fundamental molecular function that underlies cell-cell adhesion, junctional signaling, and tissue organization. Its mechanisms involve cis and trans cadherin interactions, cytoplasmic catenin and afadin recruitment, and regulation by calcium and the actin cytoskeleton [4,6,8]. Dysregulation of cadherin binding contributes to cancer, immune dysfunction, developmental defects, and host-pathogen interactions [1,3,5,7]. CRISPR-based models are powerful tools for dissecting cadherin binding mechanisms and validating therapeutic targets. EDITGENE supports this research with knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to cadherin binding studies.